Profound Medical (PROF) Receivables (2018 - 2026)

Profound Medical has reported Receivables for 9 years, with the latest figure at $9.6 million in Q1 2026.

• For the quarter ending Q1 2026, Receivables rose 91.71% year-over-year to $9.6 million; the trailing twelve-month figure through Mar 2026 stood at $9.6 million (up 91.71% YoY), and the FY2025 full-year result was $7.3 million, down 1.02% from the prior year.
• Receivables for Q1 2026 stood at $9.6 million, up from $7.3 million in the prior quarter.
• The five-year high for Receivables was $9.6 million in Q1 2026, with the low at $4.3 million in Q2 2025.
• Average Receivables over 5 years is $6.7 million, with a median of $6.7 million recorded in 2024.
• Year-over-year, Receivables slumped 38.49% in 2025 and jumped 91.71% in 2026.
• Tracing PROF's Receivables over 5 years: stood at $6.4 million in 2022, then advanced by 16.53% to $7.4 million in 2023, then slipped by 0.72% to $7.4 million in 2024, then fell by 1.02% to $7.3 million in 2025, then surged by 31.85% to $9.6 million in 2026.
• The last three Receivables figures came in at $9.6 million (Q1 2026), $7.3 million (Q4 2025), and $8.3 million (Q3 2025), per Business Quant data.

Peer Comparison